Stay updated on Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s footer now shows a new ClinicalTrials.gov site revision (v3.5.3 rather than v3.5.2), reflecting an update to the platform version rather than changes to the clinical trial record itself.SummaryDifference0.1%

- Check22 days agoChange DetectedA new revision entry v3.5.2 was added to the history and the previous v3.5.0 entry was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision history updated to include a new revision v3.5.0 and remove the older v3.4.3.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded revision v3.4.3 to the record history and removed revision v3.4.2.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded site revision v3.4.2 to the history and removed an older funding notice and revision (v3.4.1). These edits affect display metadata rather than the trial record data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check94 days agoChange DetectedAdded a site-wide funding notice and updated the page version to v3.4.1. The previous version v3.4.0 was removed.SummaryDifference0.9%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.